Transaction
Oyass Capital's Investment in Eyone Medical's Operations in Senegal for USD 1.7 million
- Announced
- 27 February 2026
- Target
- Eyone SARL
- Value
- $1.8m
- Asset class
- Venture Capital
- Type
- Investment
- Instrument
- Ordinary Shares (Equity)
- Lead investors
- Oyass Capital
- Investors
- Oyass Capital
- Sector
- Healthcare / Digital Health Platforms, Health Care Administration
- Markets
- Gabon, Mali, Cameroon, Senegal, Côte d'Ivoire
About the target
Eyone Medical is a digital health technology company that provides interconnected healthcare solutions connecting patients, healthcare providers, insurers, international organisations, and governments across Africa. The company's flagship product, the Dossier Patient Unique Partagé (Shared Patient Record), digitises healthcare pathways and enables real-time access to medical and financial records. In December 2024, Eyone secured USD 1 million in funding led by SONATEL's VIF fund and BICIS Groupe, the Senegalese affiliate of BNP Paribas. In July 2025, Eyone Medical secured 1.7 billion CFA ($3 million) from Oyass Capital, Senegal's sovereign wealth fund-backed investment vehicle.
Sources
- techbuild.africa
- Partner Researchers